Table 4.
Allopurinol group |
Control group |
|||
---|---|---|---|---|
baseline | last follow-up | baseline | last follow-up | |
Upro/creat, mg/g | 959.9 ± 1,046.3 | 1,219.3 ± 1,063.6 | 835.9 ± 599.7 | 1,170.4 ± 951.9 |
eGFR, mg/dl | 69.5 ± 26.5 | 73.2 ± 34.8 | 63.6 ± 27.5 | 68.9 ± 36.6 |
UA, mg/dl | 7.9 ± 1.1 | 5.7 ± 0.7*, # | 7.8 ± 1.1 | 7.4 ± 1.5** |
TG, mmol/l | 1.7 ± 1.4 | 1.5 ± 0.8 | 1.6 ± 0.9 | 1.7 ± 0.8 |
TC, mmol/l | 4.8 ± 0.9 | 4.6 ± 0.8 | 5.3 ± 1.3 | 5.2 ± 1.2 |
HDL, mmol/l | 1.2 ± 0.3 | 1.2 ± 0.2 | 1.3 ± 0.4 | 1.3 ± 0.3 |
LDL, mmol/l | 3.1 ± 1.0 | 2.9 ± 0.8 | 3.2 ± 1.1 | 3.3 ± 1.4 |
Compared with the baseline: * p < 0.001; ** p = 0.03.
Compared with the control group at the end of the study: # p < 0.001.